Prospects for improved bluetongue vaccines. - Wikidata - wikimedia - TriplyDB

Prospects for improved bluetongue vaccines.

Prospects for improved bluetongue vaccines.

http://www.wikidata.org/entity/Q37369882

about

Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8 Bluetongue virus coat protein VP2 contains sialic acid-binding domains, and VP5 resembles enveloped virus fusion proteins.Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.Reconstitution of authentic nanovirus from multiple cloned DNAs.RCDI/eRCDI: a web-server to estimate codon usage deoptimization.A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge Development of plant-produced protein body vaccine candidates for bluetongue virus.Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge.An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model.Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle Oncolytic bluetongue viruses: promise, progress, and perspectives Non-structural protein NS3/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis.Technical transformation of biodefense vaccines.Virus-like particle vaccines and adjuvants: the HPV paradigm.Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.Bluetongue vaccines in Europe.Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation A Rapid Field-Deployable Reverse Transcription-Insulated Isothermal Polymerase Chain Reaction Assay for Sensitive and Specific Detection of Bluetongue Virus.Expected Net Benefit of Vaccinating Rangeland Sheep against Bluetongue Virus Using a Modified-Live versus Killed Virus Vaccine A rapid assay for detecting antibody against Bluetongue virus with a latex agglutination test using recombinant VP7 antigen.Sheep breed and shearing influences attraction and blood-feeding behaviour of Culicoides (Diptera: Ceratopogonidae) on a UK farm

P2860

Q27315250-480B2378-4C2B-4A9C-861E-24C69AF6708D Q27319898-FD55178D-F586-4633-9AFC-ED9AC15C4DFC Q27660311-BFF2B8F1-F700-4B9E-AA5C-B6E30E48DFA4 Q30242080-EA8168EE-59D0-4A33-9E82-779675D605A8 Q33490901-F1470385-6552-4B20-B6C6-D0A6210E5D10 Q33548140-F19FF557-6BC4-4C76-8BE9-70A52ED91CC9 Q33621078-917F2BDF-5D2E-4537-BEDA-F60DB73F5B7E Q33743132-340B108F-45DF-4EDF-B496-BEFC1012A260 Q34204054-6CC1CD10-0491-46CD-B251-CBEAB2DC5A0C Q34236757-F1EC983C-6D2E-4D47-AE2A-944590D65A47 Q34347583-E3B1E766-A45D-40B3-AC11-A9794C233D6E Q35084491-CF93E9E4-C94A-42AD-B223-61B7D0E05FBB Q36070650-632FA0AF-D7F6-4272-8004-B4F9DEFF816F Q37058898-EEBA00F2-AFB9-408A-8A02-BB76C06B506B Q37608311-D7CF9395-9C3E-4719-83C7-5335239E4321 Q37643307-36C6E654-8C3E-4188-8ED0-25E3C6040EEF Q37896583-F97D5052-DE4F-403C-862D-4E43AD1E5D0D Q39225711-EB0E2771-2379-4F61-9883-4F4E0578AF17 Q40719691-51FED6FD-0E76-4192-8252-9DE9F6FD4630 Q42700291-50B25186-72EC-470C-852D-500F93BA6A33 Q45378070-131E38D8-1290-4B6E-8E2F-00A5B983D6E4 Q57006713-9382AB61-B589-4273-B471-1DD0835EFF41

P2860

Prospects for improved bluetongue vaccines.

http://www.wikidata.org/entity/Q37369882

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prospects for improved bluetongue vaccines.

@en

Prospects for improved bluetongue vaccines.

@nl

type

label

Prospects for improved bluetongue vaccines.

@en

Prospects for improved bluetongue vaccines.

@nl

prefLabel

Prospects for improved bluetongue vaccines.

@en

Prospects for improved bluetongue vaccines.

@nl

P1433

Q37369882-6C8956B9-1CC3-4DB7-B1BD-F7EA580F7E7A

P1476

Q37369882-EE2412A6-B6DB-45FD-B352-BFD3BB72732C

P2093

Q37369882-763D6B76-11F5-4450-9C06-17868DEC74C7

Q37369882-BB3E1E4D-2DA5-4314-B313-D240B57325A4

Q37369882-F6A5C34B-AF22-43F7-A61E-C2E317367812

P2860

Q37369882-000DD88E-5A3C-4F85-BBD4-3472A07DF11C

Q37369882-01613D9B-D913-4FFA-800B-52E69FD75DC2

Q37369882-01D5AB32-7A8B-4226-8C45-DA5D3FC4574E

Q37369882-037F18F6-48DD-4D69-A90B-49BA4ED1DA26

Q37369882-03AED187-84B6-44FA-BF69-CF379140A282

Q37369882-068F9B58-FBC2-4475-9780-DD293B02D043

Q37369882-122C2150-20BD-407C-8191-099CE4137B0E

Q37369882-1BEF4773-28ED-4430-85DB-5C57D4D0E8FA

Q37369882-219B77D6-CBE5-4D27-B130-D538BA770B21

Q37369882-246FF094-030D-459D-8DB8-7320D9A43254

P2888

Q37369882-30E8B6A0-B318-44C5-B575-3A121E8BE7C4

P304

Q37369882-CB609119-787B-4F1B-BB80-47B1BC672A94

P31

Q37369882-B9924E0F-7EF1-435E-AACC-FB0E0609C757

P356

Q37369882-390F3489-64E0-4097-8D28-4B7540DC802D

P407

Q37369882-4006A4C4-4372-45F9-A31B-A5F785847B52

P433

Q37369882-ED08ACC9-70FB-4773-B8A8-A019F05A5F88

P478

Q37369882-D8AB608B-F1CC-4E92-A9B5-6335FF81B0D4

P577

Q37369882-92EACB66-FD61-4B32-B524-60D7C3AD0767

P6179

Q37369882-79135B07-B765-4696-8DCE-B41AE739773E

P698

Q37369882-0E05F6A4-06AF-4289-B1BD-636F9815DC42

P356

P1433

Nature Reviews Microbiology

P1476

Prospects for improved bluetongue vaccines.

@en

P2093

Mark Boyce

http://www.w3.org/2001/XMLSchema#string

Polly Roy

http://www.w3.org/2001/XMLSchema#string

Robert Noad

http://www.w3.org/2001/XMLSchema#string

P2860

Virus attenuation by genome-scale changes in codon pair bias

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Climate change and the recent emergence of bluetongue in Europe

Bluetongue in Europe and the Mediterranean Basin: history of occurrence prior to 2006.

Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.

Virus-like particles as immunogens.

Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control.

Reovirus reverse genetics: Incorporation of the CAT gene into the reovirus genome.

Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts.

Quadrivalent human papillomavirus vaccine.

P2888

P304

120-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRMICRO2052

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009239996

http://www.w3.org/2001/XMLSchema#string

P698

19148179

http://www.w3.org/2001/XMLSchema#string